JAZZ logo

Jazz Pharmaceuticals (JAZZ) Operating profit

annual operating profit:

$726.63M+$129.05M(+21.60%)
December 31, 2024

Summary

  • As of today (May 21, 2025), JAZZ annual operating income is $726.63 million, with the most recent change of +$129.05 million (+21.60%) on December 31, 2024.
  • During the last 3 years, JAZZ annual operating profit has risen by +$556.35 million (+326.73%).
  • JAZZ annual operating profit is now -5.07% below its all-time high of $765.46 million, reached on December 31, 2020.

Performance

JAZZ Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

quarterly operating profit:

-$55.89M-$246.66M(-129.30%)
March 1, 2025

Summary

  • As of today (May 21, 2025), JAZZ quarterly operating income is -$55.89 million, with the most recent change of -$246.66 million (-129.30%) on March 1, 2025.
  • Over the past year, JAZZ quarterly operating profit has dropped by -$132.10 million (-173.34%).
  • JAZZ quarterly operating profit is now -121.48% below its all-time high of $260.21 million, reached on September 30, 2024.

Performance

JAZZ quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

TTM operating profit:

$594.53M-$132.10M(-18.18%)
March 1, 2025

Summary

  • As of today (May 21, 2025), JAZZ TTM operating income is $594.53 million, with the most recent change of -$132.10 million (-18.18%) on March 1, 2025.
  • Over the past year, JAZZ TTM operating profit has increased by +$47.80 million (+8.74%).
  • JAZZ TTM operating profit is now -23.67% below its all-time high of $778.87 million, reached on March 31, 2021.

Performance

JAZZ TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

JAZZ Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+21.6%-173.3%+8.7%
3 y3 years+326.7%-163.8%+521.2%
5 y5 years+13.1%-137.6%-1.1%

JAZZ Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+326.7%-121.5%at low-18.2%+521.2%
5 y5-year-5.1%+326.7%-121.5%+19.7%-23.7%+521.2%
alltimeall time-5.1%+616.8%-121.5%+49.8%-23.7%+410.8%

JAZZ Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$55.89M(-129.3%)
$594.53M(-18.2%)
Dec 2024
$726.63M(+21.6%)
$190.77M(-26.7%)
$726.63M(+7.4%)
Sep 2024
-
$260.21M(+30.5%)
$676.36M(+14.9%)
Jun 2024
-
$199.44M(+161.7%)
$588.54M(+7.6%)
Mar 2024
-
$76.21M(-45.8%)
$546.73M(-8.5%)
Dec 2023
$597.58M(+16.7%)
$140.50M(-18.5%)
$597.58M(+5.1%)
Sep 2023
-
$172.39M(+9.4%)
$568.70M(+2.5%)
Jun 2023
-
$157.64M(+24.1%)
$554.72M(+0.5%)
Mar 2023
-
$127.06M(+13.8%)
$551.77M(+7.7%)
Dec 2022
$512.27M(+200.8%)
$111.61M(-29.5%)
$512.27M(+13.8%)
Sep 2022
-
$158.41M(+2.4%)
$450.03M(+40.6%)
Jun 2022
-
$154.69M(+76.7%)
$319.99M(+234.3%)
Mar 2022
-
$87.55M(+77.3%)
$95.71M(-43.8%)
Dec 2021
$170.28M(-77.8%)
$49.38M(+74.1%)
$170.28M(-48.4%)
Sep 2021
-
$28.37M(-140.8%)
$330.31M(-35.0%)
Jun 2021
-
-$69.59M(-142.9%)
$508.15M(-34.8%)
Mar 2021
-
$162.12M(-22.6%)
$778.87M(+1.8%)
Dec 2020
$765.46M(+19.2%)
$209.41M(+1.6%)
$765.46M(+24.0%)
Sep 2020
-
$206.21M(+2.5%)
$617.29M(+3.6%)
Jun 2020
-
$201.13M(+35.2%)
$595.96M(-0.9%)
Mar 2020
-
$148.72M(+142.8%)
$601.32M(-6.4%)
Dec 2019
$642.35M(-2.3%)
$61.24M(-66.9%)
$642.35M(-16.2%)
Sep 2019
-
$184.88M(-10.5%)
$766.16M(-0.5%)
Jun 2019
-
$206.48M(+8.8%)
$770.06M(+1.4%)
Mar 2019
-
$189.74M(+2.5%)
$759.67M(+15.5%)
Dec 2018
$657.73M(+7.2%)
$185.06M(-2.0%)
$657.73M(+5.8%)
Sep 2018
-
$188.78M(-3.7%)
$621.88M(+4.6%)
Jun 2018
-
$196.09M(+123.3%)
$594.56M(+5.1%)
Mar 2018
-
$87.81M(-41.2%)
$565.51M(-7.9%)
Dec 2017
$613.84M(-0.3%)
$149.21M(-7.6%)
$613.84M(-2.6%)
Sep 2017
-
$161.45M(-3.3%)
$630.14M(+1.6%)
Jun 2017
-
$167.04M(+22.7%)
$619.94M(-0.3%)
Mar 2017
-
$136.14M(-17.7%)
$621.63M(+1.0%)
Dec 2016
$615.40M(+14.0%)
$165.50M(+9.4%)
$615.40M(+4.7%)
Sep 2016
-
$151.25M(-10.4%)
$588.05M(+3.5%)
Jun 2016
-
$168.74M(+29.9%)
$568.33M(+2.8%)
Mar 2016
-
$129.91M(-6.0%)
$552.90M(+2.4%)
Dec 2015
$539.74M
$138.15M(+5.0%)
$539.74M(+0.2%)
Sep 2015
-
$131.53M(-14.2%)
$538.70M(-0.3%)
Jun 2015
-
$153.30M(+31.3%)
$540.20M(+9.4%)
DateAnnualQuarterlyTTM
Mar 2015
-
$116.76M(-14.8%)
$494.00M(+12.9%)
Dec 2014
$437.58M(+26.7%)
$137.10M(+3.1%)
$437.58M(+10.8%)
Sep 2014
-
$133.04M(+24.2%)
$394.97M(+8.7%)
Jun 2014
-
$107.10M(+77.5%)
$363.49M(+9.0%)
Mar 2014
-
$60.34M(-36.1%)
$333.45M(-3.4%)
Dec 2013
$345.30M(+74.5%)
$94.50M(-6.9%)
$345.30M(+8.5%)
Sep 2013
-
$101.55M(+31.8%)
$318.18M(+17.0%)
Jun 2013
-
$77.07M(+6.8%)
$271.93M(+16.1%)
Mar 2013
-
$72.19M(+7.1%)
$234.29M(+18.4%)
Dec 2012
$197.84M(+54.8%)
$67.38M(+21.8%)
$197.84M(+17.7%)
Sep 2012
-
$55.30M(+40.3%)
$168.13M(+14.7%)
Jun 2012
-
$39.43M(+10.3%)
$146.53M(+3.9%)
Mar 2012
-
$35.74M(-5.1%)
$140.97M(+10.3%)
Dec 2011
$127.83M(+121.2%)
$37.66M(+11.7%)
$127.83M(+10.5%)
Sep 2011
-
$33.70M(-0.5%)
$115.70M(+20.0%)
Jun 2011
-
$33.86M(+49.8%)
$96.44M(+31.8%)
Mar 2011
-
$22.60M(-11.5%)
$73.16M(+26.6%)
Dec 2010
$57.79M(+262.8%)
$25.54M(+76.8%)
$57.79M(+32.3%)
Sep 2010
-
$14.44M(+36.5%)
$43.66M(+32.6%)
Jun 2010
-
$10.58M(+46.4%)
$32.93M(+8.4%)
Mar 2010
-
$7.23M(-36.6%)
$30.38M(+90.7%)
Dec 2009
$15.93M(-111.3%)
$11.41M(+207.6%)
$15.93M(-191.4%)
Sep 2009
-
$3.71M(-53.8%)
-$17.44M(-64.3%)
Jun 2009
-
$8.03M(-211.2%)
-$48.89M(-53.0%)
Mar 2009
-
-$7.22M(-67.1%)
-$104.02M(-26.0%)
Dec 2008
-$140.60M(+1.3%)
-$21.96M(-20.9%)
-$140.60M(-20.7%)
Sep 2008
-
-$27.74M(-41.1%)
-$177.39M(+5.9%)
Jun 2008
-
-$47.09M(+7.5%)
-$167.44M(+2.7%)
Mar 2008
-
-$43.81M(-25.4%)
-$163.10M(+17.5%)
Dec 2007
-$138.78M(+77.8%)
-$58.74M(+230.1%)
-$138.78M(-27.4%)
Sep 2007
-
-$17.80M(-58.4%)
-$191.27M(+18.2%)
Jun 2007
-
-$42.75M(+119.4%)
-$161.80M(+50.7%)
Mar 2007
-
-$19.48M(-82.5%)
-$107.37M(+37.6%)
Dec 2006
-$78.05M(+36.6%)
-$111.23M(-1052.9%)
-$78.05M(+94.9%)
Sep 2006
-
$11.67M(0.0%)
-$40.04M(-13.6%)
Jun 2006
-
$11.67M(+18.7%)
-$46.35M(-12.0%)
Mar 2006
-
$9.84M(-113.4%)
-$52.67M(-7.8%)
Dec 2005
-$57.14M
-$73.23M(-1465.9%)
-$57.14M(-455.3%)
Sep 2005
-
$5.36M(0.0%)
$16.08M(+50.0%)
Jun 2005
-
$5.36M(0.0%)
$10.72M(+100.0%)
Mar 2005
-
$5.36M
$5.36M

FAQ

  • What is Jazz Pharmaceuticals annual operating income?
  • What is the all time high annual operating profit for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals annual operating profit year-on-year change?
  • What is Jazz Pharmaceuticals quarterly operating income?
  • What is the all time high quarterly operating profit for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals quarterly operating profit year-on-year change?
  • What is Jazz Pharmaceuticals TTM operating income?
  • What is the all time high TTM operating profit for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals TTM operating profit year-on-year change?

What is Jazz Pharmaceuticals annual operating income?

The current annual operating profit of JAZZ is $726.63M

What is the all time high annual operating profit for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high annual operating income is $765.46M

What is Jazz Pharmaceuticals annual operating profit year-on-year change?

Over the past year, JAZZ annual operating income has changed by +$129.05M (+21.60%)

What is Jazz Pharmaceuticals quarterly operating income?

The current quarterly operating profit of JAZZ is -$55.89M

What is the all time high quarterly operating profit for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high quarterly operating income is $260.21M

What is Jazz Pharmaceuticals quarterly operating profit year-on-year change?

Over the past year, JAZZ quarterly operating income has changed by -$132.10M (-173.34%)

What is Jazz Pharmaceuticals TTM operating income?

The current TTM operating profit of JAZZ is $594.53M

What is the all time high TTM operating profit for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high TTM operating income is $778.87M

What is Jazz Pharmaceuticals TTM operating profit year-on-year change?

Over the past year, JAZZ TTM operating income has changed by +$47.80M (+8.74%)
On this page